Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 2, 1996, Pages 164-168

  Thuma, Philip E ^a   Weiss, Gunter ^b   Herold, Manfred ^b   Gordeuk, Victor R ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEFEROXAMINE; INTERLEUKIN 4; INTERLEUKIN 6; IRON CHELATE; NEOPTERIN; PLACEBO; PYRIMETHAMINE; QUININE; SULFADOXINE;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BRAIN MALARIA; CLINICAL ARTICLE; DISEASE DURATION; DOSE RESPONSE; FEVER; HELPER CELL; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

EID: 0029978760     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.164     Document Type: Article

References (32)

1. Harpaz R, Edelman R, Wasserman SS, Levine MM, Davis JR, Stein MB, 1992. Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest 90: 515-523.
2. Hviid L, Jakobsen PH, Abu-zeid YA, Theander TG, 1992. T-cell responses in malaria. APMIS 100: 95-106.
3. Mshana RN, Boulandi J, Mshana NM, Mayombo J, Mendome G, 1991. Cytokines in the pathogenesis of malaria: levels of IL-1beta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol 34: 131-139.
4. Mosmann TR, Coffman RL, 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
5. Romagagni S, 1992. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today 13: 379-381.
6. Roitt IM, Brostoff J, Male DK, 1993. Immunology. Third edition. St Louis, MO: Mosby Publishing Co , 7-8.
7. Taylor-Robinson AW, Phillips RS, Moncada S, Liew FY, 1993. The role of TH1 and TH2 cells in a rodent malaria infection. Science 260: 1931-1934.
8. Von der Weid T, Kopf M, Kohler G, Langhorne J, 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 24: 2285-2293.
9. Mellouk S, Green SJ, Nacy CA, Hoffman SL, 1991. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol 146: 3971-3976.
10. Nussler A, Drapier JC, Renia L, Pied S, Miltgen F, Gentilin M, Mazier D, 1991. L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur J Immunol 21: 227-230.
11. Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, Hentze MW, 1994. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 180: 969-976.
12. Bunnag D, Poltera AA, Viravan C, Looareesuwan S, Harinasuta KT, Schindlery C, 1992. Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Trop 52: 59-67.
13. Gordeuk VR, Thuma PE, Brittenham GM, Zulu S, Simwanza G, Mhango A, Flesch G, Parry D, 1992. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 79: 308-312.
14. Gordeuk VR, Thuma PE, Brittenham GM, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E, Vargas L, Gilkeson R, Poltera AA, 1992. Effect of iron chelator therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 327: 1472-1477.
15. Weiss G, Fuchs D, Hausen A. Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H, 1992. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol 20: 605-610.
16. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, 1989. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27: 81-141.
17. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H, 1988. Neopterin as a marker of activated cell-mediated immunity: application in HIV infection. Immunol Today 9: 150-155.
18. Paul WE, 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859-1870.
19. Van Gameren MM, Willemse PHB, Mulder NH, Limburg PC, Groen HJM, Vellenga E, de Vries EGE, 1994. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84: 1434-1441.
20. Taboue MD, Muanza K, Lyagoubi M, Jardel C, Pied S, Amedee-Manesma O, Grau GE, Mazier D, 1992. The role of interleukin 6 in vitamin A deficiency during Plasmodium falciparum malaria and possible consequences for vitamin A supplementation. Immunology 75: 553-554.
21. Molyneuk ME, Taylor TE, Wirima JJ, Borgstein A, 1989. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-459.
22. Picot S, Petron F, Vuillez JP, Barbe G, Deloron P, Jacob MC, Chumpitazi B, Boudin C, Sheik-Zakkiudin I, Ambrose-Thomas P. 1993. Neopterin levels in plasma during a longitudinal study in an area endemic for malaria. Clin Immunol and Immunopathol 67: 273-276.
23. Blumberg N, Heal JM, 1989. Transfusion and recipient immune function. Arch Pathol Lab Med 113: 246-253
24. Liew FY, 1989. Functional heterogeneity of CD4+ cells in leishmaniasis. Immunol Today 10: 40-45.
25. Kanagawa O, Vaupel BA, Gayama S, Koehler G, Kopf M, 1993. Resistance of mice deficient to IL-4 to retrovirus-induced immunodeficiency syndrome (MAIS). Science 240: 240-242.
26. Leal LC, Moss DW, Kuhn R, Muller W, Liew FY, 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur J Immunol 23: 566-569.
27. Cenci E, Romani L, Menacacci A, Spaccapelo R, Schiaffella E, Puccetti O, Bistoni F, 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23: 1034-1038.
28. Liew FY, 1993. The role of nitric oxide in parasitic diseases. Ann Trop Med Parasitol 87: 637-642.
29. Brown AE, Webster HK, Teja-Isavadharm P, Keeratithakul D, 1990. Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin Exp Immunol 82: 97-101.
30. Fuchs D, Zangerle R, Weiss G, Fritsch P, Tilz GP, Dierich MP, Wachter H, 1993. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 50: 90-96.
31. Means RT, Krantz SB, 1992. Progress in understanding the pathogenesis of anemia of chronic disease. Blood 80: 1639-1648.
32. Cellard-Peyle F, Dieye A, Vitris M, Gaye M, Marcoux L, Poli L, Saissy JM, Sarthou JL, 1991. Neuropaludisme et cytokines. Dakar Medi 36: 198-202.